What will Ginkgo Bioworks foundry revenue be in the first quarter of 2023?

Started Sep 15, 2022 07:00PM UTC
Closing Apr 01, 2023 03:59AM UTC

Topics

Science and Technology Synthetic Biology in the Energy Sector

Seasons

2022 Season 2023 Season

Scaling production of synthetic biology processes remains a key challenge (Institution of Engineering and Technology, Harvard Business Review). Gingko Bioworks foundry and codebase offers a platform to facilitate scaling both the research and production processes of their customers by programming and manufacturing cells on their behalf (Gingko Bioworks, Forbes, Nasdaq). These “cell programs” allow companies to manufacture food, pharmaceutical, and petrochemical products through biological processes (Gingko Bioworks).

This question will be resolved based on Ginkgo Bioworks’ first quarter financial report, which can be found on their investment web page. Foundry revenue for Q2 2022 can be found on slide 12 of the Q2 presentation and page 7 of the SEC filing.

Additional Resources:

How a Bioworks Startup is Trying to Reprogram the World (Bloomberg)

Possible Answer	Crowd Forecast	Change in last 24 hours	Change in last week	Change in last month
Less than $30 million	5.13%	+0.08%	-1.14%	-3.13%
More than or equal to $30 million but less than $45 million	19.13%	+0.07%	-2.36%	-3.31%
More than or equal to $45 million but less than $60 million	49.80%	-0.13%	+2.83%	+6.51%
More than or equal to $60 million but less than $75 million	23.47%	-0.02%	+0.62%	+1.67%
More than or equal to $75 million	2.47%	+0.00%	+0.06%	-1.74%